Evaluation of appropriate nutrient intake for patients treated with sodium-glucose-cotransporter-2 inhibitor.
Not Applicable
- Conditions
- type2 diabetes
- Registration Number
- JPRN-UMIN000025536
- Lead Sponsor
- Shizuoka General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with hypersensitivity to Dapaglifozin 2. Type1 diabetes 3. Subjects with severe ketosis,diabetic coma or precoma 4. Subjects with severe infection,befor and after surgery or severe injury 5. Pregnancy 6. Past history of acute coronary syndrome 7. Malignancy 8. Patients who attending physicians consider to be inappropriate due to other reasons mentioned above
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method